|
September 9, 2021
|
Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research
|
|
|
September 7, 2021
|
Neoleukin Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
|
|
|
August 5, 2021
|
Neoleukin Therapeutics Announces Second Quarter 2021 Financial Results & Provides Corporate Update
|
|
|
August 4, 2021
|
Neoleukin Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
|
|
|
May 26, 2021
|
Neoleukin Therapeutics to Participate in Jefferies Virtual Healthcare Conference
|
|
|
May 12, 2021
|
Neoleukin Therapeutics Announces First Quarter 2021 Financial Results and Corporate Update
|
|
|
May 5, 2021
|
Neoleukin Therapeutics Announces Initiation of Phase 1 NL-201 Trial
|
|
|
May 4, 2021
|
Neoleukin Therapeutics to Participate in BofA Securities 2021 Healthcare Conference
|
|
|
May 3, 2021
|
Neoleukin Therapeutics Announces Appointment of Priti Patel, M.D., M.S., as Chief Medical Officer
|
|
|
April 26, 2021
|
Neoleukin Therapeutics Announces Clearance to Proceed with NL-201 Phase 1 Clinical Trial in the United States
|
|
